HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicola Silvestris Selected Research

Antineoplastic Agents (Antineoplastics)

1/2020On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents.
8/2019Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa' Italiana di Nefrologia (SIN) multidisciplinary consensus position paper.
9/2012Antineoplastic drug-induced bradyarrhythmias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicola Silvestris Research Topics

Disease

129Neoplasms (Cancer)
04/2024 - 01/2005
32Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 01/2009
20Breast Neoplasms (Breast Cancer)
03/2023 - 09/2001
18Hepatocellular Carcinoma (Hepatoma)
01/2023 - 04/2013
15Neoplasm Metastasis (Metastasis)
01/2023 - 06/2012
15Pancreatic Neoplasms (Pancreatic Cancer)
06/2022 - 06/2013
12Stomach Neoplasms (Stomach Cancer)
12/2023 - 01/2003
12COVID-19
08/2023 - 01/2020
10Adenocarcinoma
06/2022 - 09/2015
9Melanoma (Melanoma, Malignant)
02/2024 - 04/2011
8Inflammation (Inflammations)
04/2024 - 10/2016
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2023 - 12/2005
7Biliary Tract Neoplasms (Biliary Tract Cancer)
02/2024 - 12/2015
7Triple Negative Breast Neoplasms
03/2023 - 04/2012
5Multiple Myeloma
04/2024 - 04/2011
5Glioblastoma (Glioblastoma Multiforme)
01/2024 - 04/2011
5Head and Neck Neoplasms (Head and Neck Cancer)
07/2020 - 02/2010
5Neutropenia
02/2020 - 01/2003
5Carcinogenesis
09/2015 - 01/2011
4Glioma (Gliomas)
05/2023 - 01/2021
4Microsatellite Instability
06/2022 - 12/2011
4Lung Neoplasms (Lung Cancer)
04/2022 - 06/2018
3Monoclonal Gammopathy of Undetermined Significance
04/2024 - 02/2020
3Prostatic Neoplasms (Prostate Cancer)
05/2023 - 01/2005
3Drug-Related Side Effects and Adverse Reactions
03/2023 - 01/2023
3Sarcoma (Soft Tissue Sarcoma)
02/2023 - 04/2011
3Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 01/2022
3Cholangiocarcinoma
01/2023 - 02/2017
3Infections
08/2021 - 01/2020
3Hypertension (High Blood Pressure)
12/2017 - 09/2012
3Colonic Neoplasms (Colon Cancer)
08/2017 - 01/2009
2Atherosclerosis
04/2024 - 01/2023
2Sudden Infant Death (SID)
04/2024 - 08/2023
2Myocardial Infarction
01/2023 - 03/2005
2Cardiotoxicity
11/2022 - 09/2012
2Lymphoma (Lymphomas)
05/2022 - 09/2014
2Virus Diseases (Viral Diseases)
02/2022 - 08/2021
2Fatigue
01/2022 - 11/2007
2Carcinoma (Carcinomatosis)
11/2021 - 03/2005

Drug/Important Bio-Agent (IBA)

21Immune Checkpoint InhibitorsIBA
02/2024 - 04/2019
17Proteins (Proteins, Gene)FDA Link
04/2024 - 06/2012
17MicroRNAs (MicroRNA)IBA
01/2024 - 09/2013
17Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2010
15Sorafenib (BAY 43-9006)FDA Link
02/2022 - 01/2015
11Monoclonal AntibodiesIBA
08/2019 - 01/2009
10Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 12/2011
10GemcitabineFDA Link
01/2020 - 02/2005
9CytokinesIBA
12/2023 - 01/2018
9Cetuximab (Erbitux)FDA Link
09/2015 - 01/2009
8Immune Checkpoint ProteinsIBA
05/2022 - 04/2019
8Capecitabine (Xeloda)FDA Link
01/2022 - 06/2003
8ErbB Receptors (EGF Receptor)IBA
08/2019 - 01/2009
7Tyrosine Kinase InhibitorsIBA
08/2023 - 01/2011
7RNA (Ribonucleic Acid)IBA
05/2023 - 08/2019
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2019 - 04/2012
6VaccinesIBA
08/2023 - 01/2020
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 02/2005
4Messenger RNA (mRNA)IBA
04/2024 - 01/2022
4B7-H1 AntigenIBA
01/2021 - 07/2020
4Paclitaxel (Taxol)FDA LinkGeneric
02/2020 - 02/2005
4Panitumumab (Vectibix)FDA Link
09/2015 - 01/2009
3pembrolizumabIBA
02/2024 - 06/2020
3TamoxifenFDA LinkGeneric
03/2023 - 09/2001
3Programmed Cell Death 1 ReceptorIBA
02/2023 - 06/2020
3AntibodiesIBA
02/2023 - 07/2020
3NivolumabIBA
01/2023 - 06/2020
3CateninsIBA
07/2022 - 10/2017
3Docetaxel (Taxotere)FDA Link
01/2022 - 01/2003
3Epirubicin (Ellence)FDA LinkGeneric
01/2022 - 01/2015
3durvalumabIBA
06/2021 - 06/2020
3Metformin (Glucophage)FDA LinkGeneric
01/2021 - 01/2015
3PlatinumIBA
12/2020 - 12/2005
3Tumor Biomarkers (Tumor Markers)IBA
09/2020 - 01/2014
3Angiogenesis InhibitorsIBA
02/2020 - 03/2016
3Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 09/2012
3folfirinoxIBA
01/2020 - 11/2013
3Phosphotransferases (Kinase)IBA
10/2019 - 01/2011
3ParaffinIBA
08/2019 - 02/2013
3130-nm albumin-bound paclitaxelIBA
05/2019 - 01/2014
3Bevacizumab (Avastin)FDA Link
07/2016 - 02/2015
3Vinorelbine (Navelbine)FDA LinkGeneric
07/2015 - 06/2003
2Proteasome Endopeptidase Complex (Proteasome)IBA
04/2024 - 02/2020
2Small Interfering RNA (siRNA)IBA
12/2023 - 01/2022
2regorafenibIBA
08/2023 - 11/2021
2Interleukin-2 (IL2)IBA
05/2023 - 06/2021
21-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2023 - 11/2021
2Zn(II)-phthalocyanine (zinc phthalocyanine)IBA
03/2023 - 11/2021
2COVID-19 VaccinesIBA
01/2023 - 01/2021
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
02/2022 - 04/2013
2AntigensIBA
01/2022 - 07/2020
2DNA (Deoxyribonucleic Acid)IBA
12/2021 - 08/2019
2LigandsIBA
11/2021 - 06/2020

Therapy/Procedure

76Therapeutics
05/2023 - 09/2001
55Drug Therapy (Chemotherapy)
02/2024 - 06/2003
29Immunotherapy
04/2024 - 10/2016
10Radiotherapy
05/2022 - 02/2010
5Chemoradiotherapy
01/2022 - 02/2010
4Precision Medicine
02/2022 - 01/2017
3Neoadjuvant Therapy
01/2022 - 09/2001
2Photochemotherapy (Photodynamic Therapy)
03/2023 - 11/2021